Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care

Downloads

Download data is not yet available.

References

Scrimenti A, Seabury RW, Miller CD, Ruangvoravat L, Darko W, Probst LA, Cwikla GM. Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit. Pharmacy Practice. 2019;17(4):1541. https://doi.org/10.18549/PharmPract.2019.4.1541

Ko A, Harada MY, Barmparas G, Chung K, Mason R, Yim DA, Dhillon N, Margulies DR, Gewertz BL, Ley EJ. Association between enoxaparin dosage adjusted by anti–factor Xa trough level and clinically evident venous thromboembolism after trauma. JAMA Surg. 2016;151(11):1006-1013. https://doi.org/10.1001/jamasurg.2016.1662

Singer GA, Riggi G, Karcutskie CA, Vaghaiwalla TM, Lieberman HM, Ginzburg E, Namias N, Lineen EB. Anti-Xa–guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients. J Trauma Acute Care Surg. 2016;81(6):1101-1108. https://doi.org/10.1097/TA.0000000000001193

Ohta H, Miyake T, Shimuzu T, Sonoda H, Ueki T, Kaida S, Yamaguchi T, Iida H, Tani M. The impact of pharmacological thromboprophylaxis and disease-stage on postoperative bleeding following colorectal cancer surgery. World J Surg Oncol. 2019 Jun 27;17(1):110. https://doi.org/10.1186/s12957-019-1653-1

Sun G, Wu J, Wang Q, Liang Q, Jia J, Cheng K, Sun G, Wang Z. Factor Xa inhibitors and direct thrombin inhibitors versus low-molecular-weight heparin for thromboprophylaxis after total hip or total knee arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2019;34(4):789-800. https://doi.org/10.1016/j.arth.2018.11.029

Published
2020-02-17
How to Cite
1.
Zachariah S, Al-Tamimi M, Vippadapu P, Shenouda W, Thomas D. Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care. Pharm Pract (Granada) [Internet]. 2020Feb.17 [cited 2020Mar.28];18(1):1808. Available from: https://pharmacypractice.org/journal/index.php/pp/article/view/1808
Section
Letters to the Editor